Chanitra Thuwajit

2 Wang Lang Road
Bangkok Noi, 10700, Thailand

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications

NECTIN2 depletion impairs migration and invasion in MDA-MB-231 breast cancer cells through LIMK1-associated cytoskeletal remodeling.

NECTIN2 depletion impairs migration and invasion in MDA-MB-231 breast cancer cells through LIMK1-associated cytoskeletal remodeling.

Journal: PloS one
Published: April 22, 2026

Prognostic and therapeutic importance of TROP-2 and MUC-1 in non-small cell lung cancer: A systematic review and meta-analysis.

Prognostic and therapeutic importance of TROP-2 and MUC-1 in non-small cell lung cancer: A systematic review and meta-analysis.

Journal: Biomedical reports
Published: April 14, 2026

HLA class I-specific nucleolin peptides induce therapeutic T cells in triple-negative breast cancer patients.

HLA class I-specific nucleolin peptides induce therapeutic T cells in triple-negative breast cancer patients.

Journal: International journal of biological sciences
Published: January 30, 2026

Next-generation of mesothelin-targeted CAR-T cells secreting anti-PD-L1 scFv for potent immunotherapy against 3D patient-derived colorectal cancer organoids.

Next-generation of mesothelin-targeted CAR-T cells secreting anti-PD-L1 scFv for potent immunotherapy against 3D patient-derived colorectal cancer organoids.

Journal: BMC medicine
Published: December 30, 2025

Dual Targeting of FAP-Directed Nanoparticles and FRα-Specific CAR-T Cells Induces Additive Anti-Tumor Effects in Triple-Negative Breast Cancer.

Dual Targeting of FAP-Directed Nanoparticles and FRα-Specific CAR-T Cells Induces Additive Anti-Tumor Effects in Triple-Negative Breast Cancer.

Journal: International journal of biological sciences
Published: July 25, 2025

Stromal transcriptomics uncover LIF as a key effector in high tumor budding triple-negative breast cancer.

Stromal transcriptomics uncover LIF as a key effector in high tumor budding triple-negative breast cancer.

Journal: Scientific reports
Published: June 30, 2025

Unraveling the role of ChREBP in lung adenocarcinoma: Expression, regulatory networks, and potential functional impact.

Unraveling the role of ChREBP in lung adenocarcinoma: Expression, regulatory networks, and potential functional impact.

Journal: PloS one
Published: March 01, 2025

SynProtX: a large-scale proteomics-based deep learning model for predicting synergistic anticancer drug combinations.

SynProtX: a large-scale proteomics-based deep learning model for predicting synergistic anticancer drug combinations.

Journal: GigaScience
Published: December 21, 2024

Identification of Transcriptional Regulators of Immune Evasion Across Cancers: An Alternative Immunotherapeutic Strategy for Cholangiocarcinoma.

Identification of Transcriptional Regulators of Immune Evasion Across Cancers: An Alternative Immunotherapeutic Strategy for Cholangiocarcinoma.

Journal: Cancers
Published: October 09, 2024

In silico advancements in Peptide-MHC interaction: A molecular dynamics study of predicted glypican-3 peptides and HLA-A*11:01.

In silico advancements in Peptide-MHC interaction: A molecular dynamics study of predicted glypican-3 peptides and HLA-A*11:01.

Journal: Heliyon
Published: August 15, 2024

Development of cancer-associated fibroblasts-targeting polymeric nanoparticles loaded with 8-O-methylfusarubin for breast cancer treatment.

Development of cancer-associated fibroblasts-targeting polymeric nanoparticles loaded with 8-O-methylfusarubin for breast cancer treatment.

Journal: International journal of pharmaceutics: X
Published: July 17, 2024

Identification of Tumor Budding-Associated Genes in Breast Cancer through Transcriptomic Profiling and Network Diffusion Analysis.

Identification of Tumor Budding-Associated Genes in Breast Cancer through Transcriptomic Profiling and Network Diffusion Analysis.

Journal: Biomolecules
Published: June 25, 2024
Showing 1-12 of 64

Last Updated: 09/26/2026